A study of neoadjuvant sintilimab combined with chemotherapy TP for locally advanced esophageal squamous cell carcinoma (ESCC).

被引：0
|
作者：
Li, Zhao
Xu, Peng-Fei
Mao, Wei-Min
Kuang, YuKang
Fan, Hai-Yin
Zou, Bin
Zhu, Jian-Feng
Li, Chao
Cheng, Xiao-Liang
Liu, Xing-Fei
Guo, Changying
机构：
[1] Jiangxi Prov Tumor Hosp, Nanchang, Peoples R China
[2] Nanchang Univ, Jiangxi Prov Tumor Hosp, Med Coll, Nanchang, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16038
引用
收藏
页码：E16038 / E16038
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC-ESCC2019): A multicenter, phase 2 study
    Liu, Jun
    Li, Jingpei
    Lin, Wanli
    Shao, Di
    Depypere, Lieven
    Zhang, Zhifeng
    Li, Zhuoyi
    Cui, Fei
    Du, Zesen
    Zeng, Yuan
    Jiang, Shunjun
    He, Ping
    Gu, Xia
    Chen, Huai
    Zhang, Hai
    Lin, Xiaowei
    Huang, Haoda
    Lv, Wenqiang
    Cai, Weiming
    Liang, Wenhua
    Liang, Hengrui
    Jiang, Wenxi
    Wang, Wei
    Xu, Ke
    Cai, Weipeng
    Wu, Kui
    Lerut, Toni
    Fu, Junhui
    He, Jianxing
    INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (01) : 128 - 137
  • [22] NEOADJUVANT CAMRELIZUMAB IN COMBINATION WITH ALBUMIN PACLITAXEL AND CISPLATIN FOR PATIENTS WITH LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
    Lv, Huilai
    Tian, Yang
    Li, Zhenhua
    Huang, Chao
    Xu, Yanzhao
    Tian, Ziqiang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A587 - A587
  • [23] The efficacy and safety of induction chemotherapy combined with sintilimab followed by concurrent chemoradiotherapy plus sintilimab sequencing maintaining with sintilimab for patients with unresectable locally advanced esophageal squamous cell carcinoma
    Wang, Ruifeng
    Guo, Tianhui
    Wang, Qi
    Gao, Wen
    Yu, Yimiao
    Zhang, Jun
    Fu, Wenqian
    Wang, Haiji
    Zhang, Biyuan
    BMC CANCER, 2025, 25 (01)
  • [24] Neoadjuvant camrelizumab combined with chemotherapy and apatinib for locally advanced thoracic esophageal squamous cell carcinoma (ESCC): A single-arm, open-label, phase Ib study.
    Wang, Zhen
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [25] Neoadjuvant chemoradiotherapy versus chemotherapy and surgery for patients with locally advanced esophageal squamous cell carcinoma
    Hao, Daxuan
    Li, Xue
    Yang, Yuanyuan
    Zhang, Yougai
    Wu, Xiaoyuan
    Chen, Yongshun
    He, Chunyu
    Wang, Wen
    Liu, Jinsong
    Wang, Jianhua
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [26] Neoadjuvant PD-1 Plus Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
    Qian, Ting
    Liu, Delin
    Cao, Guochun
    Chen, Zhipeng
    Zhang, Qin
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2024, 23
  • [27] Neoadjuvant chemoradiotherapy versus chemotherapy and surgery for patients with locally advanced esophageal squamous cell carcinoma
    Hao, Daxuan
    Li, Xue
    Yang, Yuanyuan
    Zhang, Yougai
    Wu, Xiaoyuan
    Chen, Yongshun
    Wang, Jianhua
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 (02) : 346 - 353
  • [28] The efficacy and safety of neoadjuvant camrelizumab and chemotherapy for locally advanced thoracic esophageal squamous cell carcinoma
    Xu, Weili
    Jiang, Youhua
    Wang, Changchun
    Wu, Jie
    Li, Jianqiang
    Hu, Yuqian
    Lu, Weishan
    Shen, Dijian
    Wang, Yinjie
    Chen, Qixun
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [29] Survival outcomes of neoadjuvant immunochemotherapy versus chemotherapy for locally advanced esophageal squamous cell carcinoma
    Lv, Huilai
    Zhang, Fan
    Huang, Chao
    Xu, Shi
    Li, Jiachen
    Sun, Bokang
    Gai, Chunyue
    Liu, Zhao
    Wang, Mingbo
    Li, Zhenhua
    Tian, Ziqiang
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (05)
  • [30] Efficacy and safety of neoadjuvant chemotherapy and immunotherapy in locally resectable advanced esophageal squamous cell carcinoma
    Wu, Zhigang
    Zheng, Qiang
    Chen, Haiquan
    Xiang, Jiaqing
    Hu, Hong
    Li, Hang
    Pan, Yunjian
    Peng, Yizhou
    Yao, Xingxin
    Liu, Pengcheng
    Sun, Yihua
    Li, Bin
    Zhang, Yawei
    JOURNAL OF THORACIC DISEASE, 2021, 13 (06) : 3518 - 3528
12345